Strategies for Surveillance, Prevention, and Control of Arbovirus Diseases in Western North America

BACKGROUND: The novel Coronavirus Diseases 2019 (COVID-19) is the major public health burden in the world. The morbidity and mortality of global community due to this disease is dramatically increasing from time to time. OBJECTIVE: This situational analysis is aimed to analysis prevalence, and incidence of COVID-19 and to provide clear information about this disease for the scientific community, stakeholders and healthcare practitioners and decision-makers. METHODS: The literatures were identified by searching the key relevant and officially known online databases: medRxiv, Google scholar and PubMed. The online databases contain archives of most English biomedical journals and scientific papers published online from 31 December to 3 April 2020 were included. After the literature search, articles were screened independently by two reviewers for eligibility. RESULTS: The world continents have confirmed a total of 1,202,320 confirmed COVID-19 cases: (51.2%) in Europe, (27.7%) in North America, (17.9%) in Asia, (1.96%) in South America and at less number of confirmed COVID-19 cases in Africa and Australia which was accounted 0.8% and 0.5%, respectively. However, this review showed that there was significantly increased the confirmed COVID-19 cases by 109,555 in Asia, 8,658 in Africa, 332,866 in North America, 20,269 in South America, 568,894 in Europe, 5,051 in Australia and 1,045,403 in the whole world continent except Antarctica during the review period. The overall results showed that there were 1,098,762 cases and 59,172 deaths have recorded from during the review period. The result zero number of deaths with COVID-19 was observed in 66 countries. CONCLUSION: The review concluded that COVID-19; SARS-CoV-2 is the major public health burden in the world, the morbidity and mortality of global community is dramatically increasing from time to time. Strongly collaboration among all sectors and then design effective prevention and control strategies which include staying home, social/physical distancing, quarantine, testing of suspected patients, isolation and managing of the confirmed cases. Therefore, the world continents countries should have to implement five major COVID-19 prevention and control programmes as soon as possible at community level.

Download Full-text

La Crosse virus: a scoping review of the global evidence

Epidemiology and Infection ◽

10.1017/s0950268818003096 ◽

2018 ◽

Vol 147 ◽

Cited By ~ 5

Author(s):

S. Harding ◽

J. Greig ◽

M. Mascarenhas ◽

I. Young ◽

L. A. Waddell

Keyword(s):

Climate Change ◽

North America ◽

Scoping Review ◽

Prevention And Control ◽

Social Impact ◽

La Crosse Virus ◽

California Serogroup ◽

And Control ◽

The Impact ◽

Global Evidence

AbstractUrbanisation and climate change are altering the pattern of California serogroup viruses in North America. As La Crosse virus (LACV) is the most pathogenic of the California serogroup, it is important to identify changes in distribution, transmission and pathogenesis. A scoping review (ScR) was prioritised to summarise the global evidence on LACV. A comprehensive search strategy was used, identified references were screened for relevance and relevant articles were characterised. Each step was conducted by two independent reviewers using pre-tested forms. Analysis identified areas of research saturation and gaps. The ScR included 481 research articles that were mostly journal articles (78.2%) conducted in North America (90.9%) from 1969 to 2016. Most evidence focused on epidemiology (44.9%), virus characteristics (25.8%), transmission conditions (18.7%) and pathogenesis of LACV in hosts (18.3%). Fewer studies evaluated the accuracy of diagnostic tests (8.7%), the efficacy of treatments (3.5%), prevention and control strategies (3.1%), the economic burden of infection (0.6%) and social impact (0.2%) of LACV. None of the literature predicted the impact of climate change on LACV, nor were any cases reported in Canada. These findings are intended to guide research to close knowledge gaps and inform evidence-based decisions surrounding activities for the prevention and control of LACV.

Download Full-text

Lyme disease ecology in a changing world: consensus, uncertainty and critical gaps for improving control

Philosophical Transactions of the Royal Society B Biological Sciences ◽

10.1098/rstb.2016.0117 ◽

2017 ◽

Vol 372 (1722) ◽

pp. 20160117 ◽

Cited By ~ 61

Author(s):

A. Marm Kilpatrick ◽

Andrew D. M. Dobson ◽

Taal Levi ◽

Daniel J. Salkeld ◽

Andrea Swei ◽

...

Keyword(s):

North America ◽

Lyme Disease ◽

Disease Ecology ◽

Prevention And Control ◽

Disease Risk ◽

Policy Implications ◽

Spatial And Temporal Variation ◽

Tick Feeding ◽

Tick Abundance ◽

And Control

Lyme disease is the most common tick-borne disease in temperate regions of North America, Europe and Asia, and the number of reported cases has increased in many regions as landscapes have been altered. Although there has been extensive work on the ecology and epidemiology of this disease in both Europe and North America, substantial uncertainty exists about fundamental aspects that determine spatial and temporal variation in both disease risk and human incidence, which hamper effective and efficient prevention and control. Here we describe areas of consensus that can be built on, identify areas of uncertainty and outline research needed to fill these gaps to facilitate predictive models of disease risk and the development of novel disease control strategies. Key areas of uncertainty include: (i) the precise influence of deer abundance on tick abundance, (ii) how tick populations are regulated, (iii) assembly of host communities and tick-feeding patterns across different habitats, (iv) reservoir competence of host species, and (v) pathogenicity for humans of different genotypes of Borrelia burgdorferi . Filling these knowledge gaps will improve Lyme disease prevention and control and provide general insights into the drivers and dynamics of this emblematic multi-host–vector-borne zoonotic disease. This article is part of the themed issue ‘Conservation, biodiversity and infectious disease: scientific evidence and policy implications'.

Download Full-text